168434-02-4 (O-去乙基坎地沙坦,O-Desethyl Candesartan)

2-氨基-4-溴噻唑;O-去乙基坎地沙坦;坎地沙坦酯杂质;坎地沙坦杂质6;

1H-Benzimidazole-4-carboxylicacid, 2,3-dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-;2-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-benzimidazole-4-carboxylic acid;O-Desethyl Candesartan;CV 15959;2,3-Dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-1H-benziMidazole-4-carboxylic Acid;2,3-Dihydro-2-oxo-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]- 4-yl]Methyl]-1H-benziMidazole-4-carboxylic Acid;Q27288196;168434-02-4;RMN65A337Y;SCHEMBL4935797;2-hydroxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid;DTXSID60434746;2-oxo-3-{[2'-(1H-tetrazol-5-yl)[biphenyl]-4-yl]methyl}-2,3-dihydro-1H-benzimidazole-4-carboxylic acid;CHEBI:145224;UNII-RMN65A337Y;2-Oxo-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-2,3-dihydro-1H-benzimidazole-4-carboxylic acid;CV-15959;1H-Benzimidazole-4-carboxylic acid, 2,3-dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-;1H-Benzimidazole-4-carboxylic acid, 2,3-dihydro-2-oxo-3-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-;O-Desethylcandesartan;AKOS030254783;Candesartan Impurity 6;

KLCPKPIDOPBIQW-UHFFFAOYSA-N

1S/C22H16N6O3/c29-21(30)17-6-3-7-18-19(17)28(22(31)23-18)12-13-8-10-14(11-9-13)15-4-1-2-5-16(15)20-24-26-27-25-20/h1-11H,12H2,(H,23,31)(H,29,30)(H,24,25,26,27)

O=C1NC2C=CC=C(C(=O)O)C=2N1CC1C=CC(C2=CC=CC=C2C2N=NNN=2)=CC=1